Showing results (141-150 of 156) with videos related to
Sort By:
Pageof 16
Blood|April 29, 2009
Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemiaCarlos M Santamaría, María C Chillón, Ramón García-Sanz, et al.Leukemia Research|May 22, 2009
High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogeneticsCarlos M Santamaría, Maria C Chillón, Ramón García-Sanz, et al.Orphanet Journal of Rare Diseases|May 5, 2017
Diagnosis features of pediatric Gaucher disease patients in the era of enzymatic therapy, a national-base study from the Spanish Registry of Gaucher DiseaseMarcio Andrade-Campos, Pilar Alfonso, Pilar Irun, et al.Leukemia & Lymphoma|March 23, 2002
Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myelomaJuan José Lahuerta, Carlos Grande, Joan Blade, et al.Blood|December 16, 2015
Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysisBruno Paiva, María Victoria Mateos, Luis Ignacio Sanchez-Abarca, et al.Blood|March 14, 2008
Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patientsSandra Quijano, Antonio López, Ana Rasillo, et al.Seminars in Hematology|October 7, 2004
Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patientsNeal J Weinreb, Mario C Aggio, Hans C Andersson, et al.Journal of Lipid Research|January 3, 2016
Glucosylated cholesterol in mammalian cells and tissues: formation and degradation by multiple cellular β-glucosidasesAndré R A Marques, Mina Mirzaian, Hisako Akiyama, et al.Journal of the National Cancer Institute|March 23, 2011
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinibCarlo Gambacorti-Passerini, Laura Antolini, François-Xavier Mahon, et al.American Journal of Hematology|February 17, 2015
Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use programValentín García-Gutiérrez, Alejandra Martinez-Trillos, Jose Luis Lopez Lorenzo, et al.Pageof 16